Skip to main content
. 2017 Nov 28;103(1):105–114. doi: 10.1210/jc.2017-01516

Table 2.

CGM Intervention and Metrics of Glycemic Control

Variable Run-in 3 mo 6 mo 9 mo 12 mo 15 mo 18 mo
Dexcom/Medtronic (n/n) 7/4 7/4 7/4 7/4 7/4 7/4 7/4
Insulin requirement (U·kg−1·d−1) 0.5 ± 0.1 0.5 ± 0.0 0.5 ± 0.0 0.5 ± 0.0
Mean glucose (mg/dL) 157 ± 6 159 ± 8 165 ± 10 170 ± 12 166 ± 11 158 ± 7 157 ± 8
Glucose SDa (mg/dL) 71 ± 5 68 ± 6 66 ± 4 68 ± 6 69 ± 6 64 ± 5 63 ± 4
Time with glucose > 180 mg/dL (%) 34 ± 4 32 ± 5 36 ± 5 37 ± 6 35 ± 5 32 ± 4 32 ± 5
Time with glucose < 60 mg/dL (%) 6.5 ± 1.6 4.3 ± 1.2 4.1 ± 1.0 3.6 ± 0.8 3.9 ± 0.8 4.0 ± 0.7 4.0 ± 0.7
Dayb time with glucose < 60 mg/dL (%) 6.2 ± 1.9 3.9 ± 1.1 3.5 ± 0.7 3.6 ± 0.8 3.5 ± 0.7 3.9 ± 0.7 3.6 ± 0.6
Nocturnalc time with glucose < 60 mg/dL (%) 6.8 ± 1.6 5.7 ± 1.7 6.2 ± 2.0 4.1 ± 1.6 5.1 ± 1.7 4.8 ± 1.6 5.2 ± 1.7
No. of severe hypoglycemic events per yd 2.2 ± 0.7 1.4 ± 0.6 1.2 ± 0.7 0.9 ± 0.5

Unless otherwise noted, data are mean ± standard error of the mean.

a

P = 0.07.

b

Day hours defined as 0600 to 0000.

c

Nocturnal hours defined as 0000 to 0600.

d

P < 0.01.